# Using FAPI PET/MRI to Evaluate Prostate Cancer

> **NCT06675357** · PHASE2 · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer Metastatic Disease
- Prostate Cancers

## Interventions

- **RADIATION:** FAPI
- **PROCEDURE:** Positron Emission Tomography (PET)
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT06675357
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06675357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06675357, "Using FAPI PET/MRI to Evaluate Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06675357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*